Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today's News: Middle East.
Press releases published on August 8, 2025
Morepen Laboratories Limited Expands to UAE: Step-Down Subsidiary in Dubai Mainland Support from Start Any Business
DUBAI, DUBAI, UNITED ARAB EMIRATES, August 8, 2025 /EINPresswire.com/ -- Morepen Laboratories Limited, a renowned Indian pharmaceutical giant, has successfully established its new step-down subsidiary in the Dubai Mainland under the name Morepen Medical …
BLM Releases Draft EIS for the Grassy Mountain Gold Project
WINNEMUCCA, Nev., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Paramount Gold Nevada Corp. (NYSE American: PZG) (“Paramount” or the “Company”) is pleased to announce that the U.S. Bureau of Land Management (“BLM”) has released its draft Environmental Impact Statement …
SaverOne Signs Agreement with Sdot Dan Regional Council to Deploy SaverOne System in its School Bus Fleet
Sdot Dan becomes the latest regional council in central Israel to implement the SaverOne System to protect school children Petah Tikvah, Israel, Aug. 08, 2025 (GLOBE NEWSWIRE) -- SaverOne 2014 Ltd. (Nasdaq: SVRE, TASE: SVRE), a technology company …
Terra Balcanica Lists on OTCQB Marketplace
Vancouver, British Columbia, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Terra Balcanica Resources Corp. (“Terra” or the “Company”) (CSE:TERA; FRA:UB10) is pleased to announce that its common shares have begun trading on the OTCQB marketplace under the symbol “TEBAF …
Tenaya Therapeutics to Participate in the Canaccord Genuity 45th Annual Growth Conference
SOUTH SAN FRANCISCO, Calif., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying …
MAX Power Closes Financings for $4.45 Million with Eric Sprott as Lead Order
VANCOUVER, British Columbia, Aug. 08, 2025 (GLOBE NEWSWIRE) -- MAX Power Mining Corp. (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) (“MAX Power” or the “Company”) is pleased to announce that in conjunction with the previously announced closings of its non- …
Gauzy Ltd. Announces Board of Directors Changes Following Annual Meeting
Gauzy Pleased to Announce Alejandro Weinstein, Former Director in Gauzy, Elected to Board; A Long-Time Investor and Shareholder Engaged with the Company Since 2016 Gauzy Adopts Leaner Board to Reduce Corporate Expenses and Maintain Agility TEL AVIV, Israel …
Spectral Medical Announces Second Quarter and Provides Corporate Update
Topline Tigris results expected to be released around mid-August 2025 TORONTO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and …
First American Uranium Announces Shares for Debt
Vancouver, British Columbia, Aug. 08, 2025 (GLOBE NEWSWIRE) -- First American Uranium Inc. (CSE: URM) (FSE: IOR) (OTCPK: FAUMF) (the “Company”) announces that, it will enter into a debt settlement agreement for the issuance of 2,000,000 common shares in …
ParaZero’s DefendAir System Triumphs in Field Trial, Unveiling Advanced Counter-Drone Defense Solution
Kfar Saba, Israel, Aug. 08, 2025 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) …
Orchestra BioMed Announces Rollout of FDA-Approved BACKBEAT Global Pivotal Study Protocol Update Significantly Expanding Patient Eligibility
FDA-approved protocol update significantly expands patient eligibility criteria for the BACKBEAT global pivotal study (“BACKBEAT study”), resulting in an estimated more than 24-fold increase in the potentially eligible patient pool as compared to original …
Y-mAbs Reports Second Quarter 2025 Financial Results and Recent Corporate Developments
Reported Total Revenues of $19.5 million for the second quarter of 2025, exceeding the high end of the Company’s guidance range of between $17 million and $19 million SERB Pharmaceuticals to acquire Y-mAbs in $412.0 million transaction; transaction …
Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter and First Half 2025
Tokyo, Japan and Cambridge, UK, 8 August 2025 – Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) provides an update on operational activities and reports its consolidated results for the second quarter and first half ended 30 June 2025. The full report …